Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner

Yoshikazu Takada, Masaaki Fujita

研究成果: 書貢獻/報告類型章節

4 引文 (Scopus)

摘要

Secreted phospholipase A2 type IIA (sPLA2-IIA) is a well-established pro-inflammatory protein and has been a major target for drug discovery. However, the mechanism of its signaling action has not been fully understood. We previously found that sPLA2-IIA binds to integrins αvβ3 and α4β1 in human and that this interaction plays a role in sPLA2-IIA’s signaling action. Our recent studies found that sPLA2-IIA activates integrins in an allosteric manner through direct binding to a newly identified binding site of integrins (site 2), which is distinct from the classical RGD-binding site (site 1). The sPLA2-IIA-induced integrin activation may be related to the signaling action of sPLA2-IIA. Since sPLA2-IIA is present in normal human tears in addition to rheumatoid synovial fluid at high concentrations the sPLA2-IIA-mediated integrin activation on leukocytes may be involved in immune responses in normal and pathological conditions.

原文英語
主出版物標題Advances in Experimental Medicine and Biology
發行者Springer New York LLC
頁面103-115
頁數13
925
DOIs
出版狀態已發佈 - 2017

出版系列

名字Advances in Experimental Medicine and Biology
925
ISSN(列印)0065-2598
ISSN(電子)2214-8019

指紋

Secretory Phospholipase A2
Integrins
Chemical activation
Binding Sites
Synovial Fluid
Drug Discovery
Tears
Leukocytes
Fluids

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

引用此文

Takada, Y., & Fujita, M. (2017). Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner. 於 Advances in Experimental Medicine and Biology (卷 925, 頁 103-115). (Advances in Experimental Medicine and Biology; 卷 925). Springer New York LLC. https://doi.org/10.1007/5584_2016_95

Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner. / Takada, Yoshikazu; Fujita, Masaaki.

Advances in Experimental Medicine and Biology. 卷 925 Springer New York LLC, 2017. p. 103-115 (Advances in Experimental Medicine and Biology; 卷 925).

研究成果: 書貢獻/報告類型章節

Takada, Y & Fujita, M 2017, Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner. 於 Advances in Experimental Medicine and Biology. 卷 925, Advances in Experimental Medicine and Biology, 卷 925, Springer New York LLC, 頁 103-115. https://doi.org/10.1007/5584_2016_95
Takada Y, Fujita M. Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner. 於 Advances in Experimental Medicine and Biology. 卷 925. Springer New York LLC. 2017. p. 103-115. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/5584_2016_95
Takada, Yoshikazu ; Fujita, Masaaki. / Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner. Advances in Experimental Medicine and Biology. 卷 925 Springer New York LLC, 2017. 頁 103-115 (Advances in Experimental Medicine and Biology).
@inbook{61b2014fb4b24f5da952c9907f5ab931,
title = "Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner",
abstract = "Secreted phospholipase A2 type IIA (sPLA2-IIA) is a well-established pro-inflammatory protein and has been a major target for drug discovery. However, the mechanism of its signaling action has not been fully understood. We previously found that sPLA2-IIA binds to integrins αvβ3 and α4β1 in human and that this interaction plays a role in sPLA2-IIA’s signaling action. Our recent studies found that sPLA2-IIA activates integrins in an allosteric manner through direct binding to a newly identified binding site of integrins (site 2), which is distinct from the classical RGD-binding site (site 1). The sPLA2-IIA-induced integrin activation may be related to the signaling action of sPLA2-IIA. Since sPLA2-IIA is present in normal human tears in addition to rheumatoid synovial fluid at high concentrations the sPLA2-IIA-mediated integrin activation on leukocytes may be involved in immune responses in normal and pathological conditions.",
keywords = "Allosteric site, Docking simulation, Integrin activation, Secreted phospholipase A2 type IIA (sPLA2-IIA)",
author = "Yoshikazu Takada and Masaaki Fujita",
year = "2017",
doi = "10.1007/5584_2016_95",
language = "English",
volume = "925",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "103--115",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Secreted phospholipase A2 type IIA (sPLA2-IIA) activates integrins in an allosteric manner

AU - Takada, Yoshikazu

AU - Fujita, Masaaki

PY - 2017

Y1 - 2017

N2 - Secreted phospholipase A2 type IIA (sPLA2-IIA) is a well-established pro-inflammatory protein and has been a major target for drug discovery. However, the mechanism of its signaling action has not been fully understood. We previously found that sPLA2-IIA binds to integrins αvβ3 and α4β1 in human and that this interaction plays a role in sPLA2-IIA’s signaling action. Our recent studies found that sPLA2-IIA activates integrins in an allosteric manner through direct binding to a newly identified binding site of integrins (site 2), which is distinct from the classical RGD-binding site (site 1). The sPLA2-IIA-induced integrin activation may be related to the signaling action of sPLA2-IIA. Since sPLA2-IIA is present in normal human tears in addition to rheumatoid synovial fluid at high concentrations the sPLA2-IIA-mediated integrin activation on leukocytes may be involved in immune responses in normal and pathological conditions.

AB - Secreted phospholipase A2 type IIA (sPLA2-IIA) is a well-established pro-inflammatory protein and has been a major target for drug discovery. However, the mechanism of its signaling action has not been fully understood. We previously found that sPLA2-IIA binds to integrins αvβ3 and α4β1 in human and that this interaction plays a role in sPLA2-IIA’s signaling action. Our recent studies found that sPLA2-IIA activates integrins in an allosteric manner through direct binding to a newly identified binding site of integrins (site 2), which is distinct from the classical RGD-binding site (site 1). The sPLA2-IIA-induced integrin activation may be related to the signaling action of sPLA2-IIA. Since sPLA2-IIA is present in normal human tears in addition to rheumatoid synovial fluid at high concentrations the sPLA2-IIA-mediated integrin activation on leukocytes may be involved in immune responses in normal and pathological conditions.

KW - Allosteric site

KW - Docking simulation

KW - Integrin activation

KW - Secreted phospholipase A2 type IIA (sPLA2-IIA)

UR - http://www.scopus.com/inward/record.url?scp=85019420975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019420975&partnerID=8YFLogxK

U2 - 10.1007/5584_2016_95

DO - 10.1007/5584_2016_95

M3 - Chapter

C2 - 27864802

AN - SCOPUS:85019420975

VL - 925

T3 - Advances in Experimental Medicine and Biology

SP - 103

EP - 115

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -